Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene

被引:65
|
作者
O'Kusky, JR
Nasir, J
Cicchetti, F
Parent, A
Hayden, MR
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada
[3] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada
[4] Univ Laval, Ctr Rech Robert Giffard, Neurobiol Lab, Quebec City, PQ G1J 2B3, Canada
基金
英国医学研究理事会;
关键词
apoptosis; huntingtin protein; Huntington's disease; subthalamic nucleus;
D O I
10.1016/S0006-8993(98)01312-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a progressive neurodegenerative disorder associated with CAG repeat expansion within a novel gene (IT15). We have previously created a targeted disruption in exon 5 of Hdh (Hdh(ex5)), the murine homologue of the HD gene. Homozygotes for the Hdh(ex5) mutation exhibit embryolethality before embryonic day 8.5, while heterozygotes survive to adulthood and display increased motor activity and cognitive deficits. Detailed morphometric and stereological analyses of the basal ganglia in adult heterozygous mice were performed by light and electron microscopy. Morphometric analyses demonstrated a significant loss of neurons from both the globus pallidus (29 %) and the subthalamic nucleus (51 %). with a normal complement of neurons in the caudate-putamen and substantia nigra. The ultrastructural appearance of sporadic degenerating neurons in these regions indicated apoptosis. The highest frequency of apoptotic neurons was observed in the globus pallidus and subthalamic nucleus. Stereological analyses in the subthalamic nucleus revealed a significant decrease in the numerical density of symmetric synapses (43 %), suggesting a relatively selective loss of inhibitory pallido-subthalamic afferents. Immunohistochemistry using antibodies against enkephalin and substance-P was unremarkable in heterozygotes, indicating a normal complement of enkephalin-immunoreactive striatopallidal afferents and substance-P-immunoreactive striatopeduncular and striatonigral afferents in these animals. These findings show that loss of an intact huntingtin protein is associated with significant morphological alterations in the basal ganglia of adult mice, indicating an important role for this protein during development of the central nervous system. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:468 / 479
页数:12
相关论文
共 19 条
  • [1] Inhibitory Spike-Timing-Dependent Plasticity Can Account for Pathological Strengthening of Pallido-Subthalamic Synapses in Parkinson's Disease
    Madadi Asl, Mojtaba
    Asadi, Atefeh
    Enayati, Jamil
    Valizadeh, Alireza
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [2] Timing of selective basal ganglia white matter loss in premanifest Huntington's disease
    Zeun, Paul
    McColgan, Peter
    Dhollander, Thijs
    Gregory, Sarah
    Johnson, Eileanoir B.
    Papoutsi, Marina
    Nair, Akshay
    Scahill, Rachael, I
    Rees, Geraint
    Tabrizi, Sarah J.
    NEUROIMAGE-CLINICAL, 2022, 33
  • [3] Progression of basal ganglia pathology in heterozygousQ175knock-in Huntington's disease mice
    Deng, Yunping
    Wang, Hongbing
    Joni, Marion
    Sekhri, Radhika
    Reiner, Anton
    JOURNAL OF COMPARATIVE NEUROLOGY, 2021, 529 (07) : 1327 - 1371
  • [4] Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington's disease
    Zeun, P.
    McColgan, P.
    Dhollander, T.
    Gregory, S.
    Johnson, E.
    Papoutsi, M.
    Scahill, R.
    Rees, G.
    Tabrizi, S.
    MOVEMENT DISORDERS, 2020, 35 : S106 - S106
  • [5] Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease
    Blandini, F
    Nappi, G
    Greenamyre, JT
    ANNALS OF NEUROLOGY, 2001, 49 (04) : 525 - 529
  • [6] Dysregulation of the Basal Ganglia Indirect Pathway in Early Symptomatic Q175 Huntington's Disease Mice
    Callahan, Joshua W.
    Wokosin, David L.
    Bevan, Mark D.
    JOURNAL OF NEUROSCIENCE, 2022, 42 (10): : 2080 - 2102
  • [7] A novel autosomal dominant basal ganglia degeneration with cavitation on 19q can mimic Parkinson's disease and Huntington's disease.
    Burn, J
    Curtis, AR
    Bindoff, L
    Ince, P
    Coulthard, A
    Jackson, A
    Jackson, M
    Fey, C
    Hay, D
    Shepherd, D
    Bates, D
    Curtis, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 371 - 371
  • [8] Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease
    Isabel Lastres-Becker
    María Gómez
    Rosario de Miguel
    José A. Ramos
    Javier Fernández-Ruiz
    Neurotoxicity Research, 2002, 4 : 601 - 608
  • [9] Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease
    Lastres-Becker, Isabel
    Gomez, Maria
    de Miguel, Rosario
    Ramos, Jose A.
    Fernandez-Ruiz, Javier
    NEUROTOXICITY RESEARCH, 2002, 4 (7-8) : 601 - 608
  • [10] EXPRESSION OF HOMEOBOX GENE OTX2 IN THE EARLY MOUSE EMBRYO WITH TARGETED DISRUPTION OF HUNTINGTON'S DISEASE GENE. 277
    Bo Lin
    Joy M. Richman
    Pediatric Research, 1997, 41 (Suppl 4) : 49 - 49